Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors
2022 · Critical Reviews in Oncology/Hematology · 12 citations
https://doi.org/10.1016/j.critrevonc.2022.103881
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
556
Citations
12
h-index
12
i10-index
Rosario Francesco Di Stefano is an academic researcher from University of Turin. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Renal cell carcinoma treatment & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 12, co-authored 29 publications.
https://doi.org/10.1016/j.critrevonc.2022.103881
https://doi.org/10.1016/j.clgc.2024.102255
Click to start Chat